APO Research
Talk to an analyst

APO RESEARCH · REPORT

PNH and aHUS

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.

Selected research

Market Analysis & Forecast

Global PNH and aHUS Market Analysis and Forecast 2026-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchPNH and aHUS Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal PNH and aHUS Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal PNH and aHUS Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PNH and aHUS Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal PNH and aHUS Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.

United States is the largest consumption place, with a consumption market share nearly 52.1% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 26.2%.

Report Includes

Read the full market overview

This report presents an overview of global market for PNH and aHUS, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PNH and aHUS, also provides the revenue of main regions and countries. Of the upcoming market potential for PNH and aHUS, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PNH and aHUS revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PNH and aHUS market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for PNH and aHUS revenue, projected growth trends, production technology, application and end-user industry.

PNH and aHUS Segment by Company

Alexion Pharmaceuticals

Alnylam Pharmaceuticals

Omeros Corporation

PNH and aHUS Segment by Type

Soliris

Ultomiris

PNH and aHUS Segment by Application

PNH

aHUS

PNH and aHUS Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PNH and aHUS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PNH and aHUS and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PNH and aHUS.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of PNH and aHUS in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of PNH and aHUS company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PNH and aHUS revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PNH and aHUS Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Soliris Major Player Table 3. Ultomiris Major Player Table 4. Global PNH and aHUS Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. PNH Major Player Table 6. aHUS Major Player Table 7. PNH and aHUS Industry Trends Table 8. PNH and aHUS Industry Drivers Table 9. PNH and aHUS Industry Opportunities and Challenges Table 10. PNH and aHUS Industry Restraints Table 11. Global PNH and aHUS Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global PNH and aHUS Market Size by Region (2021-2026) & (US$ Million) Table 13. Global PNH and aHUS Market Share by Region (2021-2026) Table 14. Global PNH and aHUS Market Size by Region (2027-2032) & (US$ Million) Table 15. Global PNH and aHUS Market Share by Region (2027-2032) Table 16. Global PNH and aHUS Revenue by Players (US$ Million) & (2021-2026) Table 17. Global PNH and aHUS Revenue Market Share by Players (2021-2026) Table 18. Global PNH and aHUS Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global PNH and aHUS Key Players Headquarters & Area Served Table 20. Global PNH and aHUS Players, Product Type & Application Table 21. Global PNH and aHUS Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global PNH and aHUS by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global PNH and aHUS Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global PNH and aHUS Revenue by Type (2021-2026) & (US$ Million) Table 26. Global PNH and aHUS Revenue by Type (2027-2032) & (US$ Million) Table 27. Global PNH and aHUS Revenue Market Share by Type (2021-2026) Table 28. Global PNH and aHUS Revenue Market Share by Type (2027-2032) Table 29. Global PNH and aHUS Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global PNH and aHUS Revenue by Application (2021-2026) & (US$ Million) Table 31. Global PNH and aHUS Revenue by Application (2027-2032) & (US$ Million) Table 32. Global PNH and aHUS Revenue Market Share by Application (2021-2026) Table 33. Global PNH and aHUS Revenue Market Share by Application (2027-2032) Table 34. Alexion Pharmaceuticals Company Information Table 35. Alexion Pharmaceuticals Business Overview Table 36. Alexion Pharmaceuticals PNH and aHUS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Alexion Pharmaceuticals PNH and aHUS Product Portfolio Table 38. Alexion Pharmaceuticals Recent Development Table 39. Alnylam Pharmaceuticals Company Information Table 40. Alnylam Pharmaceuticals Business Overview Table 41. Alnylam Pharmaceuticals PNH and aHUS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Alnylam Pharmaceuticals PNH and aHUS Product Portfolio Table 43. Alnylam Pharmaceuticals Recent Development Table 44. Omeros Corporation Company Information Table 45. Omeros Corporation Business Overview Table 46. Omeros Corporation PNH and aHUS Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Omeros Corporation PNH and aHUS Product Portfolio Table 48. Omeros Corporation Recent Development Table 49. North America PNH and aHUS Revenue by Type (2021-2026) & (US$ Million) Table 50. North America PNH and aHUS Revenue by Type (2027-2032) & (US$ Million) Table 51. North America PNH and aHUS Revenue by Application (2021-2026) & (US$ Million) Table 52. North America PNH and aHUS Revenue by Application (2027-2032) & (US$ Million) Table 53. North America PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America PNH and aHUS Revenue by Country (2021-2026) & (US$ Million) Table 55. North America PNH and aHUS Revenue by Country (US$ Million) & (2027-2032) Table 56. Europe PNH and aHUS Revenue by Type (2021-2026) & (US$ Million) Table 57. Europe PNH and aHUS Revenue by Type (2027-2032) & (US$ Million) Table 58. Europe PNH and aHUS Revenue by Application (2021-2026) & (US$ Million) Table 59. Europe PNH and aHUS Revenue by Application (2027-2032) & (US$ Million) Table 60. Europe PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe PNH and aHUS Revenue by Country (2021-2026) & (US$ Million) Table 62. Europe PNH and aHUS Revenue by Country (US$ Million) & (2027-2032) Table 63. China PNH and aHUS Revenue by Type (2021-2026) & (US$ Million) Table 64. China PNH and aHUS Revenue by Type (2027-2032) & (US$ Million) Table 65. China PNH and aHUS Revenue by Application (2021-2026) & (US$ Million) Table 66. China PNH and aHUS Revenue by Application (2027-2032) & (US$ Million) Table 67. Asia PNH and aHUS Revenue by Type (2021-2026) & (US$ Million) Table 68. Asia PNH and aHUS Revenue by Type (2027-2032) & (US$ Million) Table 69. Asia PNH and aHUS Revenue by Application (2021-2026) & (US$ Million) Table 70. Asia PNH and aHUS Revenue by Application (2027-2032) & (US$ Million) Table 71. Asia PNH and aHUS Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia PNH and aHUS Revenue by Region (US$ Million) & (2021-2026) Table 73. Asia PNH and aHUS Revenue by Region (US$ Million) & (2027-2032) Table 74. SAMEA PNH and aHUS Revenue by Type (2021-2026) & (US$ Million) Table 75. SAMEA PNH and aHUS Revenue by Type (2027-2032) & (US$ Million) Table 76. SAMEA PNH and aHUS Revenue by Application (2021-2026) & (US$ Million) Table 77. SAMEA PNH and aHUS Revenue by Application (2027-2032) & (US$ Million) Table 78. SAMEA PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. SAMEA PNH and aHUS Revenue by Country (2021-2026) & (US$ Million) Table 80. SAMEA PNH and aHUS Revenue by Country (US$ Million) & (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. PNH and aHUS Image Figure 2. Global PNH and aHUS Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PNH and aHUS Market Size Share 2021 VS 2025 VS 2032 Figure 4. Soliris Image Figure 5. Ultomiris Image Figure 6. Global PNH and aHUS Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global PNH and aHUS Market Size Share 2021 VS 2025 VS 2032 Figure 8. PNH Image Figure 9. aHUS Image Figure 10. Global PNH and aHUS Market Size (US$ Million) & (2021-2032) Figure 11. Global PNH and aHUS Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global PNH and aHUS Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global PNH and aHUS Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global PNH and aHUS Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global PNH and aHUS Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global PNH and aHUS Revenue Market Share by Type (2021-2032) Figure 18. Global PNH and aHUS Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global PNH and aHUS Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global PNH and aHUS Revenue Market Share by Application (2021-2032) Figure 21. North America PNH and aHUS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America PNH and aHUS Revenue Share by Type (2021-2032) Figure 23. North America PNH and aHUS Revenue Share by Application (2021-2032) Figure 24. North America PNH and aHUS Revenue Share by Country (2021-2032) Figure 25. United States PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe PNH and aHUS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe PNH and aHUS Revenue Share by Type (2021-2032) Figure 30. Europe PNH and aHUS Revenue Share by Application (2021-2032) Figure 31. Europe PNH and aHUS Revenue Share by Country (2021-2032) Figure 32. Germany PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China PNH and aHUS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China PNH and aHUS Revenue Share by Type (2021-2032) Figure 42. China PNH and aHUS Revenue Share by Application (2021-2032) Figure 43. Asia PNH and aHUS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia PNH and aHUS Revenue Share by Type (2021-2032) Figure 45. Asia PNH and aHUS Revenue Share by Application (2021-2032) Figure 46. Asia PNH and aHUS Revenue Share by Region (2021-2032) Figure 47. Japan PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA PNH and aHUS Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA PNH and aHUS Revenue Share by Type (2021-2032) Figure 55. SAMEA PNH and aHUS Revenue Share by Application (2021-2032) Figure 56. SAMEA PNH and aHUS Revenue Share by Country (2021-2032) Figure 57. Brazil PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt PNH and aHUS Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Soliris
  • Ultomiris
Applications
  • PNH
  • aHUS
Companies covered
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Omeros Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PNH and aHUS Market by Type
  3. 1.2.1 Global PNH and aHUS Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Soliris
  5. 1.2.3 Ultomiris
  6. 1.3 PNH and aHUS Market by Application
  7. 1.3.1 Global PNH and aHUS Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 PNH
  9. 1.3.3 aHUS
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 PNH and aHUS Market Dynamics
  1. 2.1 PNH and aHUS Industry Trends
  2. 2.2 PNH and aHUS Industry Drivers
  3. 2.3 PNH and aHUS Industry Opportunities and Challenges
  4. 2.4 PNH and aHUS Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global PNH and aHUS Market Perspective (2021-2032)
  2. 3.2 Global PNH and aHUS Growth Trends by Region
  3. 3.2.1 Global PNH and aHUS Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PNH and aHUS Market Size by Region (2021-2026)
  5. 3.2.3 Global PNH and aHUS Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global PNH and aHUS Revenue by Players
  2. 4.1.1 Global PNH and aHUS Revenue by Players (2021-2026)
  3. 4.1.2 Global PNH and aHUS Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global PNH and aHUS Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PNH and aHUS Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global PNH and aHUS Key Players Headquarters & Area Served
  7. 4.4 Global PNH and aHUS Players, Product Type & Application
  8. 4.5 Global PNH and aHUS Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global PNH and aHUS Market CR5 and HHI
  11. 4.6.3 2025 PNH and aHUS Tier 1, Tier 2, and Tier 3
5 PNH and aHUS Market Size by Type
  1. 5.1 Global PNH and aHUS Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global PNH and aHUS Revenue by Type (2021-2032)
  3. 5.3 Global PNH and aHUS Revenue Market Share by Type (2021-2032)
6 PNH and aHUS Market Size by Application
  1. 6.1 Global PNH and aHUS Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global PNH and aHUS Revenue by Application (2021-2032)
  3. 6.3 Global PNH and aHUS Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Alexion Pharmaceuticals
  2. 7.1.1 Alexion Pharmaceuticals Company Information
  3. 7.1.2 Alexion Pharmaceuticals Business Overview
  4. 7.1.3 Alexion Pharmaceuticals PNH and aHUS Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Alexion Pharmaceuticals PNH and aHUS Product Portfolio
  6. 7.1.5 Alexion Pharmaceuticals Recent Developments
  7. 7.2 Alnylam Pharmaceuticals
  8. 7.2.1 Alnylam Pharmaceuticals Company Information
  9. 7.2.2 Alnylam Pharmaceuticals Business Overview
  10. 7.2.3 Alnylam Pharmaceuticals PNH and aHUS Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Alnylam Pharmaceuticals PNH and aHUS Product Portfolio
  12. 7.2.5 Alnylam Pharmaceuticals Recent Developments
  13. 7.3 Omeros Corporation
  14. 7.3.1 Omeros Corporation Company Information
  15. 7.3.2 Omeros Corporation Business Overview
  16. 7.3.3 Omeros Corporation PNH and aHUS Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Omeros Corporation PNH and aHUS Product Portfolio
  18. 7.3.5 Omeros Corporation Recent Developments
8 North America
  1. 8.1 North America PNH and aHUS Revenue (2021-2032)
  2. 8.2 North America PNH and aHUS Revenue by Type (2021-2032)
  3. 8.2.1 North America PNH and aHUS Revenue by Type (2021-2026)
  4. 8.2.2 North America PNH and aHUS Revenue by Type (2027-2032)
  5. 8.3 North America PNH and aHUS Revenue Share by Type (2021-2032)
  6. 8.4 North America PNH and aHUS Revenue by Application (2021-2032)
  7. 8.4.1 North America PNH and aHUS Revenue by Application (2021-2026)
  8. 8.4.2 North America PNH and aHUS Revenue by Application (2027-2032)
  9. 8.5 North America PNH and aHUS Revenue Share by Application (2021-2032)
  10. 8.6 North America PNH and aHUS Revenue by Country
  11. 8.6.1 North America PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America PNH and aHUS Revenue by Country (2021-2026)
  13. 8.6.3 North America PNH and aHUS Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe PNH and aHUS Revenue (2021-2032)
  2. 9.2 Europe PNH and aHUS Revenue by Type (2021-2032)
  3. 9.2.1 Europe PNH and aHUS Revenue by Type (2021-2026)
  4. 9.2.2 Europe PNH and aHUS Revenue by Type (2027-2032)
  5. 9.3 Europe PNH and aHUS Revenue Share by Type (2021-2032)
  6. 9.4 Europe PNH and aHUS Revenue by Application (2021-2032)
  7. 9.4.1 Europe PNH and aHUS Revenue by Application (2021-2026)
  8. 9.4.2 Europe PNH and aHUS Revenue by Application (2027-2032)
  9. 9.5 Europe PNH and aHUS Revenue Share by Application (2021-2032)
  10. 9.6 Europe PNH and aHUS Revenue by Country
  11. 9.6.1 Europe PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe PNH and aHUS Revenue by Country (2021-2026)
  13. 9.6.3 Europe PNH and aHUS Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China PNH and aHUS Revenue (2021-2032)
  2. 10.2 China PNH and aHUS Revenue by Type (2021-2032)
  3. 10.2.1 China PNH and aHUS Revenue by Type (2021-2026)
  4. 10.2.2 China PNH and aHUS Revenue by Type (2027-2032)
  5. 10.3 China PNH and aHUS Revenue Share by Type (2021-2032)
  6. 10.4 China PNH and aHUS Revenue by Application (2021-2032)
  7. 10.4.1 China PNH and aHUS Revenue by Application (2021-2026)
  8. 10.4.2 China PNH and aHUS Revenue by Application (2027-2032)
  9. 10.5 China PNH and aHUS Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PNH and aHUS Revenue (2021-2032)
  2. 11.2 Asia PNH and aHUS Revenue by Type (2021-2032)
  3. 11.2.1 Asia PNH and aHUS Revenue by Type (2021-2026)
  4. 11.2.2 Asia PNH and aHUS Revenue by Type (2027-2032)
  5. 11.3 Asia PNH and aHUS Revenue Share by Type (2021-2032)
  6. 11.4 Asia PNH and aHUS Revenue by Application (2021-2032)
  7. 11.4.1 Asia PNH and aHUS Revenue by Application (2021-2026)
  8. 11.4.2 Asia PNH and aHUS Revenue by Application (2027-2032)
  9. 11.5 Asia PNH and aHUS Revenue Share by Application (2021-2032)
  10. 11.6 Asia PNH and aHUS Revenue by Country
  11. 11.6.1 Asia PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia PNH and aHUS Revenue by Country (2021-2026)
  13. 11.6.3 Asia PNH and aHUS Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PNH and aHUS Revenue (2021-2032)
  2. 12.2 SAMEA PNH and aHUS Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA PNH and aHUS Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA PNH and aHUS Revenue by Type (2027-2032)
  5. 12.3 SAMEA PNH and aHUS Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA PNH and aHUS Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA PNH and aHUS Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA PNH and aHUS Revenue by Application (2027-2032)
  9. 12.5 SAMEA PNH and aHUS Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA PNH and aHUS Revenue by Country
  11. 12.6.1 SAMEA PNH and aHUS Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA PNH and aHUS Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA PNH and aHUS Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst